Press coverage about Molina Healthcare (NYSE:MOH) has been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Molina Healthcare earned a news impact score of 0.14 on Accern’s scale. Accern also assigned media headlines about the company an impact score of 45.4141523191686 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.
Here are some of the news stories that may have effected Accern Sentiment Analysis’s analysis:
- Stock Review for Health Care Plans Investors — CVS Health, Molina Healthcare, UnitedHealth, and Humana (medindia.net)
- BRIEF-Molina Healthcare – On Dec 4 Co Entered Commitment Letter With Suntrust Bank And SunTrust Robinson Humphrey (MOH) (markets.businessinsider.com)
- Molina Healthcare Announces Pricing of Synthetic Exchange Transaction (finance.yahoo.com)
- Sign-ups pick up in week 5 of 2018 Obamacare open enrollment -U.S. (finance.yahoo.com)
- Molina Healthcare, Inc. (MOH) Director Sells $1,177,800.00 in Stock (americanbankingnews.com)
Molina Healthcare (NYSE MOH) traded up $0.17 during trading on Thursday, reaching $74.46. The company’s stock had a trading volume of 2,632,463 shares, compared to its average volume of 1,259,688. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.29 and a quick ratio of 1.29. The firm has a market capitalization of $4,368.26, a price-to-earnings ratio of 23.76 and a beta of 0.97. Molina Healthcare has a 12 month low of $42.56 and a 12 month high of $80.74.
Molina Healthcare (NYSE:MOH) last posted its earnings results on Thursday, November 2nd. The company reported ($1.62) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.23 by ($1.85). The firm had revenue of $5.03 billion during the quarter, compared to analyst estimates of $4.95 billion. Molina Healthcare had a negative net margin of 1.76% and a positive return on equity of 17.76%. The firm’s revenue for the quarter was up 10.7% on a year-over-year basis. During the same period last year, the company posted $0.85 EPS. equities research analysts anticipate that Molina Healthcare will post -3.88 earnings per share for the current fiscal year.
A number of brokerages recently weighed in on MOH. Jefferies Group upped their price objective on Molina Healthcare from $60.00 to $64.00 and gave the stock a “hold” rating in a report on Friday, October 13th. Wolfe Research raised Molina Healthcare from a “market perform” rating to an “outperform” rating in a report on Monday, October 23rd. Morgan Stanley upped their price objective on Molina Healthcare from $68.00 to $89.00 and gave the stock an “overweight” rating in a report on Friday, November 3rd. Zacks Investment Research raised Molina Healthcare from a “sell” rating to a “hold” rating in a report on Monday, November 6th. Finally, ValuEngine lowered Molina Healthcare from a “buy” rating to a “hold” rating in a report on Friday, December 1st. Three research analysts have rated the stock with a sell rating, ten have given a hold rating and five have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of $64.30.
In other Molina Healthcare news, Director J Mario Md Molina sold 15,000 shares of the company’s stock in a transaction on Monday, December 4th. The stock was sold at an average price of $78.52, for a total value of $1,177,800.00. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, COO Terry Bayer sold 9,077 shares of the company’s stock in a transaction on Monday, November 6th. The shares were sold at an average price of $77.45, for a total value of $703,013.65. Following the completion of the sale, the chief operating officer now directly owns 74,478 shares in the company, valued at approximately $5,768,321.10. The disclosure for this sale can be found here. Insiders sold 409,523 shares of company stock worth $28,635,752 in the last three months. 6.20% of the stock is owned by corporate insiders.
COPYRIGHT VIOLATION NOTICE: “Molina Healthcare (MOH) Receiving Somewhat Favorable News Coverage, Report Shows” was posted by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are accessing this story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright and trademark legislation. The legal version of this story can be read at https://www.thelincolnianonline.com/2017/12/07/molina-healthcare-moh-receiving-somewhat-favorable-news-coverage-report-shows.html.
About Molina Healthcare
Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.
Receive News & Ratings for Molina Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.